246-20-Q-0054 Questions 07132020.docx
DOCX document 14 KB Posted
- Attached to
- Reference Laboratory and Pathology Testing Services - Oklahoma Area Federal contract opportunity
- Solicitation number
- 246-20-Q-0054
About this file
This document contains a federal contract opportunity solicitation for reference laboratory and pathology testing services in the Oklahoma area. The Indian Health Service seeks a contractor to provide reference laboratory and pathology testing, including all modalities listed in the attached test volume spreadsheet, for a base year and four option years. Quotes are due by July 20, 2020 and can be submitted electronically. The opportunity will be evaluated based on technical capabilities and qualifications (50%), past performance (30%), and price (20%). Offerors must demonstrate licenses, accreditation, medical liability insurance, and the ability to interface with Indian Health Service systems. The selected contractor will be expected to provide required reports and address all services outlined in the statement of work.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| 246-20-Q-0054 Questions 07022020.docx | DOCX document | |
| Area Test Volume 2 Additional.xlsx | XLSX spreadsheet | |
| IHS Test Volumes for Path and Lab.xls | XLS spreadsheet | |
| SOW - OCAO Laboratory and Pathology Testing Services.doc | DOC document | |
| IHS Facilities Addresses.docx | DOCX document | |
| Pt 12 solicitation clauses lab and pathology.doc | DOC document |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Questions
Are we to use SF1449 when responding to the bid? You can, or you can use your own format for pricing. You can also use Excel spreadsheet attached to solicitation.
Can the pathology/cytology utilization be separated? Data not available at this time for this question.
The detail requests under the Necroscopy Section seem to be about topics other than Necroscopy. Would you confirm that the Necroscopy section reads as desired. Yes, it is confirmed.
We do not see a line item for Medical Director fees. How do we handle the Medical Director fees? It will be part of the price per test.
DLO is asking if the COVID volume should be added to the utilization spreadsheet for pricing and part of the total fee schedule? You can add the pricing for Covid on the spreadsheet attached to the solicitation.
Can we have an extension on the RFP due to COVID 19 interruption? At this point there is no reason to extend RFP, it has been out for 3 weeks, and emailed submissions are allowed.
When is the expected award date? No anticipated dates yet.
What is the current annual laboratory spend for the hospital and clinics? It’s variable to each clinic.
File details come from the government source that posted it. Updated .